Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The nicotine patch is a transdermal delivery system that releases nicotine into the body through the skin. It is used as part of nicotine replacement therapy (NRT) to help people quit smoking by reducing withdrawal symptoms and cravings associated with stopping tobacco use. The patch provides a steady dose of nicotine over 16–24 hours and is applied daily to clean, dry, hairless skin on the upper chest, upper arm, or hip. Treatment typically involves gradually reducing the dose over several weeks to minimize withdrawal symptoms.[1][2][5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on nicotine patch.